MassMutual Private Wealth & Trust FSB Lowers Stake in Cigna Group $CI

MassMutual Private Wealth & Trust FSB cut its stake in Cigna Group (NYSE:CI) by 73.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,056 shares of the health services provider’s stock after selling 8,309 shares during the period. MassMutual Private Wealth & Trust FSB’s holdings in Cigna Group were worth $881,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Valeo Financial Advisors LLC grew its stake in Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after acquiring an additional 3,471,249 shares in the last quarter. Norges Bank purchased a new stake in shares of Cigna Group in the second quarter valued at approximately $1,110,426,000. Arrowstreet Capital Limited Partnership grew its stake in Cigna Group by 24.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock worth $829,339,000 after purchasing an additional 492,045 shares in the last quarter. Balyasny Asset Management L.P. increased its holdings in Cigna Group by 1,057.2% during the 2nd quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock worth $133,803,000 after purchasing an additional 369,775 shares during the period. Finally, Man Group plc raised its position in Cigna Group by 215.5% during the 2nd quarter. Man Group plc now owns 532,183 shares of the health services provider’s stock valued at $175,929,000 after purchasing an additional 363,510 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the topic of several research reports. Wolfe Research cut their price target on Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 15th. Cowen set a $333.00 target price on shares of Cigna Group in a report on Monday, December 15th. JPMorgan Chase & Co. cut their target price on shares of Cigna Group from $428.00 to $375.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 4th. Leerink Partners lowered their price target on shares of Cigna Group from $300.00 to $270.00 in a research report on Friday, October 31st. Finally, Raymond James Financial reissued a “strong-buy” rating on shares of Cigna Group in a report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and an average target price of $333.04.

Insiders Place Their Bets

In other Cigna Group news, CEO David Cordani purchased 4,134 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were acquired at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the purchase, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. The trade was a 2.69% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Trading Up 1.7%

NYSE CI opened at $283.97 on Friday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The company has a 50 day moving average price of $271.62 and a 200 day moving average price of $289.39. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.74. The firm has a market cap of $75.86 billion, a PE ratio of 12.53, a price-to-earnings-growth ratio of 0.98 and a beta of 0.26.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating the consensus estimate of $7.64 by $0.19. The company had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. Cigna Group’s revenue was up 9.5% compared to the same quarter last year. During the same period last year, the firm earned $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, sell-side analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th were paid a $1.51 dividend. The ex-dividend date was Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is 26.64%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.